(Press-News.org) Reston, VA (January 2, 2026)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Summaries of the newly published research articles are provided below.
Seeing Hidden Vessel Inflammation
Diagnosing inflammation in large blood vessels can be difficult, especially when standard tests appear normal. In this study, researchers tested a new PET imaging tracer that targets an inflammation-related protein, comparing it with conventional scans and blood analyses in patients and healthy volunteers to better detect and measure vascular inflammation.
Boosting Thyroid Cancer Treatment with Precision Dosing
Radioactive iodine therapy has long treated metastatic thyroid cancer but works poorly when tumors absorb less iodine. This study explores a personalized approach that combines radioactive iodine with external-beam radiation, tailoring doses using imaging and patient-specific calculations to safely deliver tumor-killing radiation in patients with low iodine uptake.
A New Target for Detecting and Treating Colorectal Cancer
Researchers developed a monoclonal antibody that targets GUCY2C, a receptor found on colorectal cancer cells. Labeled with radioactive and fluorescent tracers, the antibody enabled high-contrast PET imaging, guided surgeons to tumors during operations, and delivered targeted radiation that significantly slowed tumor growth in preclinical models.
Imaging a Key Lymphoma Target
Researchers examined CD70, a potential treatment target in lymphoma, and tested a CD70-targeted PET/CT scan in patients. Most lymphoma samples expressed CD70, and the new imaging method highlighted tumors clearly, varied by lymphoma subtype, matched CD70 levels, and performed as well as standard FDG scans—while improving detection in challenging areas like the brain.
Personalizing Radiation for Head and Neck Cancer
Most radiotherapy uses the same dose for similar cancers, but tumors behave differently. This study tested a personalized approach using two PET scans to map tumor activity and oxygen levels, then tailored radiation doses for each patient, showing that highly targeted plans could be delivered safely and effectively.
Clarifying Uncertain Liver Lesions with Advanced PET/MRI
Indeterminate liver findings are common in patients with cirrhosis and often lead to repeated scans or biopsies. In this prospective study, researchers tested a PSMA-targeted PET/MRI approach, showing it could more accurately distinguish early liver cancer from benign lesions than MRI alone.
Can AI Reliably Find Tumors on PET/CT?
An international challenge tested whether artificial intelligence models trained on one PET/CT dataset can accurately detect tumors across diverse real-world settings. Seventeen teams evaluated automated lesion segmentation on varied patient populations, scanners, and tracers, revealing strong performance in familiar data but notable drops when applied to new clinical scenarios.
Imaging Vitamin C Uptake in Cancer
High-dose vitamin C may help treat some cancers, but not all tumors respond the same way. In this prospective study, researchers used a novel PET tracer to visualize vitamin C uptake across 23 cancer types, revealing striking differences between tumors and between primary and metastatic disease.
Predicting Rheumatoid Arthritis Treatment Response Earlier
Anti-TNF therapy for rheumatoid arthritis can take months to show results, and not all patients respond. This study tested a macrophage-targeting PET/CT scan before and shortly after treatment, showing that early imaging signals in joints closely tracked disease activity months later, potentially helping clinicians assess treatment effectiveness sooner.
Tracking Immune Cells with a New PET Tracer
Macrophages play a major role in cancer and inflammatory disease but are hard to measure in living patients. In this first-in-human study, researchers tested a copper-labeled nanoparticle PET tracer, showing it was safe, circulated predictably, and accumulated in macrophage-rich sites such as tumors and sarcoidosis.
Refining Prostate Cancer Radiotherapy with PSMA PET/CT
Accurately targeting recurrent prostate cancer after surgery is critical for effective salvage radiotherapy. This study analyzed PSMA PET/CT scans of post-prostatectomy patients, revealing that many recurrences extend beyond areas covered by standard clinical guidelines. Integrating PSMA PET/CT could help better define treatment volumes and reduce missed tumor regions.
Tracking CAR-T Cells in Real Time
CAR-T therapy struggles against solid tumors, partly due to unknown cell distribution. This study used a novel “Thor” PET reporter system to track engineered CAR-T cells targeting IL13Rα2 in a melanoma mouse model, showing highly sensitive detection of as few as 3,000 cells and enabling detailed monitoring of their movement and persistence over seven weeks.
A New Target for Imaging Liver Cancer
Hepatocellular carcinoma is often hard to detect and treat in late stages. Researchers identified TSPAN8, a protein highly expressed on liver cancer cells, and developed a PET radiotracer that selectively binds TSPAN8. In mouse models, the tracer accumulated in TSPAN8-positive tumors, highlighting its potential for targeted imaging and therapy.
Hitting Cancer Cells at the Right Spot
Targeted alpha therapy kills cancer cells with high-energy radiation, but its effectiveness may depend on where the radioactive particle lands inside a cell. This study showed that directing α-emitters closer to DNA increases cell killing, while plasma membrane targeting also contributes, providing insights to optimize therapies against microscopic and larger tumors.
Comparing PET and SPECT for Precision Cancer Imaging
Accurate imaging is critical for radiopharmaceutical therapy and personalized cancer care. This study systematically compared PET and SPECT using standardized phantoms, showing PET provides higher resolution and more accurate activity measurements, while SPECT performance varies by isotope. Results highlight the importance of choosing the right imaging method and isotope for targeted therapy planning.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: January 2, 2026
2026-01-02
ELSE PRESS RELEASES FROM THIS DATE:
Delayed or absent first dose of measles, mumps, and rubella vaccination
2026-01-02
About The Study: In this cohort study of children with regular access to care, most received their measles, mumps, and rubella (MMR) vaccine on time, but the proportion not receiving the MMR vaccine by 2 years of age has increased since the COVID-19 pandemic. Children who did not receive their 2- and 4-month vaccines on time were significantly more likely to not receive any MMR vaccine by 2 years, highlighting opportunities for intervention.
Corresponding Author: To contact the corresponding author, Nina B. Masters, PhD, MPH, email ninam@truveta.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.51814)
Editor’s ...
Trends in US preterm birth rates by household income and race and ethnicity
2026-01-02
About The Study: In this population-based cross-sectional study, household income disparities in preterm birth widened over time. Black race moderated the association between income and preterm birth, underscoring the need to examine the role of racism in preterm birth disparities.
Corresponding Author: To contact the corresponding author, Erika G. Cordova-Ramos, MD, email gabriela.cordovaramos@bmc.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.50664)
Editor’s ...
Study identifies potential biomarker linked to progression and brain inflammation in multiple sclerosis
2026-01-02
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
The findings were published today in Nature Immunology and validated in both mouse models and humans.
“We think we have uncovered a potential biomarker that signals a patient is experiencing so-called ‘compartmentalized inflammation’ in the central nervous system, a phenomenon which is strongly liked ...
Many mothers in Norway do not show up for postnatal check-ups
2026-01-02
In a new study, Christine Agdestein has surveyed several aspects of the postnatal check-up. Agdestein is a specialist in general practice and a general practitioner, and is currently a PhD candidate at the Norwegian University of Science and Technology (NTNU). The research project is part of her PhD.
"An important finding is that the majority are satisfied with the 6-week check-up with their GP. This is an important offer for those who have recently given birth. GPs have an important role in postnatal care," says Christine Agdestein.
"Not much research has been done on the postnatal check-up before, and therefore it is extra rewarding that we can ...
Researchers want to find out why quick clay is so unstable
2026-01-02
Quick clay is actually an old seabed. The clay thus formed under water, but came to the surface when the landscape rose after the last ice age.
However, this clay was not so dangerous, because it was full of salt from the sea. Only when the salt in the clay was washed out of fresh water from rain and groundwater did it turn into quick clay.
But what exactly makes quick clay so unstable?
"We have made very detailed and careful simulations of the friction between clay particles," says researcher and doctor Ge Li at PoreLab and the Department of Mechanical Engineering and Production at the Norwegian University of Science ...
Superradiant spins show teamwork at the quantum scale
2026-01-02
When quantum particles work together, they can produce signals far stronger than any one particle could generate alone. This collective phenomenon, called superradiance, is a powerful example of cooperation at the quantum level. Until now, superradiance was mostly known for making quantum systems lose their energy too quickly, posing challenges for quantum technologies. But a new study published in Nature Physics turns this idea on its head— revealing that collective superradiant effects ...
Cleveland Clinic Research links tumor bacteria to immunotherapy resistance in head and neck cancer
2026-01-02
Cleveland: Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others.
Two new studies, published simultaneously in Nature Cancer, reveal that elevated levels of bacteria in the tumor microenvironment suppress immune response, driving resistance to immunotherapy in patients with head and neck squamous cell carcinoma.
“These studies shift the focus of immunotherapy resistance research beyond tumor genetics ...
First Editorial of 2026: Resisting AI slop
2026-01-01
The first Editorial of the year at Science always gives the Editor-in-Chief an opportunity to reflect on notable developments for the Science journals. In this Editorial, Holden Thorp focuses on AI, discussing how it “will allow the scientific community to do more if it picks the right ways to use it.” He revisits the journals’ policies and approaches related to AI. The journals do use select AI tools. Over the past year for example, Science has collaborated with DataSeer to evaluate adherence to its policy mandating the sharing of underlying data and code for all published ...
Joint ground- and space-based observations reveal Saturn-mass rogue planet
2026-01-01
Simultaneous ground- and space-based observations of a newly discovered free-floating planet have enabled direct measurement of its mass and distance from Earth, according to a new study. The findings offer insights into the diverse and dynamic pathways by which planets can be cast adrift into interstellar space. Although studies to date have only revealed a handful of such free-floating planets, detections are expected to increase in the coming years, particularly with the NASA Nancy Grace Roman Space Telescope campaign that is scheduled for launch in 2027, ...
Inheritable genetic variant offers protection against blood cancer risk and progression
2026-01-01
A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia. The findings offer insight into why some people are naturally more resistant to clonal expansion and age-related blood cancers despite acquiring risky mutations. As tissues age, they quietly accumulate many mutations that can drive cancer. In the blood-forming, or hematopoietic, system, such mutations often appear in otherwise healthy individuals as clonal hematopoiesis (CH), a process in which certain blood stem cell (HSC) ...